Actively hiring
Cell & Gene Therapy
Oncology Therapeutics
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Flerie
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2020
Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Umoja Biopharma pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells and generate lasting remission.

Q-Immune provides cutting-edge real-time protein network analysis for CAR-T cells, enabling accurate efficacy prediction, optimized CAR-T…

Accelerate cancer immunotherapy and cancer vaccine development with Alithea Bio's HLA immunopeptidomics platform — neoantigen discovery…

Actym Therapeutics is deploying its biologically brilliant bacteria drug delivery platform to treat cancer with powerful immunotherapies…

BREYANZI® (lisocabtagene maraleucel) is a CD19-directed, genetically modified, autologous T-cell immunotherapy for adult patients with…

Adventris Pharmaceuticals is a biotechnology company focusing on cancer immunotherapy.

Flerie 



